Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, West China Hospital, Sichuan University, No. 1 Ke Yuan 4th Road, Gao Peng ave., Chengdu, Sichuan Province, People's Republic of China.
Exp Biol Med (Maywood). 2010 Jul;235(7):877-85. doi: 10.1258/ebm.2010.009361.
Monkeys with insulin-dependent diabetes are important experimental models for islet xenotransplantation. However, with regard to diabetes induction, total pancreatectomy is a difficult operation with a high complication rate, while streptozotocin (STZ) administration may cause serious toxic effects and individual difference in metabolism. We compared two strategies involving pancreatectomy and STZ to successfully and safely induce diabetes in rhesus monkeys. Thirteen rhesus monkeys were divided into two groups: single high-dose STZ administration (80, 100 and 120 mg/kg, n = 3 for each dose) (group 1) and partial pancreatectomy (70-75%) combined with low-dose STZ (15 mg/kg, n = 4) (group 2). Induction of diabetes was evaluated by blood glucose, insulin, C-peptide, intravenous glucose tolerance test (IVGTT) and arginine stimulation test (AST). Detection of hematological and serum biochemical parameters and biopsies of pancreas, liver and kidney were periodically performed. In our study, animals in both groups developed diabetes. Serum C-peptide levels in groups 1 and 2 decreased to 0.08 +/- 0.07 and 0.35 +/- 0.06 nmol/L, respectively. IVGTT and AST indicated severely impaired glucose tolerance. Immunohistochemistry demonstrated that rare insulin-positive cells remained in the pancreas. In terms of STZ toxicity, four monkeys died 8-14 days after STZ administration (3 with 120 mg/kg STZ and 1 with 100 mg/kg STZ). Group 1 animals developed liver and kidney injury evidenced by increased alanine aminotransferase, aspartate aminotransferase, total cholesterol, LDL, triglyceride and blood urea nitrogen for one month, and histological abnormality including hepatic steatosis, renal glomerulus and tubular injury. Nevertheless, moderate histological injuries were seen in animals with 80 mg/kg STZ, with subsequent recovery. In contrast, group 2 animals displayed normal biochemical parameters and histology, with generally less risk of postoperative complications. We conclude that injection of 80 mg/kg STZ could induce diabetes with moderate injuries. Partial pancreatectomy with low-dose STZ is a safer and more reproducible method for inducing diabetes in rhesus monkeys.
患有胰岛素依赖型糖尿病的猴子是胰岛异种移植的重要实验模型。然而,对于糖尿病的诱导,全胰切除术是一种具有高并发症率的困难手术,而链脲佐菌素(STZ)的给药可能会引起严重的毒性作用和个体代谢的差异。我们比较了两种涉及胰切除术和 STZ 的策略,以成功和安全地诱导恒河猴发生糖尿病。13 只恒河猴分为两组:单次高剂量 STZ 给药(80、100 和 120mg/kg,每组 3 只)(第 1 组)和部分胰切除术(70-75%)联合低剂量 STZ(15mg/kg,n=4)(第 2 组)。通过血糖、胰岛素、C 肽、静脉葡萄糖耐量试验(IVGTT)和精氨酸刺激试验(AST)评估糖尿病的诱导。定期检测血液学和血清生化参数以及胰腺、肝脏和肾脏的活检。在我们的研究中,两组动物均发生糖尿病。第 1 组和第 2 组的血清 C 肽水平分别下降至 0.08±0.07 和 0.35±0.06nmol/L。IVGTT 和 AST 表明葡萄糖耐量严重受损。免疫组织化学显示,胰腺中仍存在少数胰岛素阳性细胞。就 STZ 毒性而言,4 只猴子在 STZ 给药后 8-14 天死亡(3 只接受 120mg/kg STZ,1 只接受 100mg/kg STZ)。第 1 组动物出现肝和肾损伤,表现为丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、总胆固醇、LDL、甘油三酯和血尿素氮升高一个月,组织学异常包括肝脂肪变性、肾小球和肾小管损伤。然而,接受 80mg/kg STZ 的动物出现中度组织学损伤,随后恢复。相比之下,第 2 组动物的生化参数和组织学正常,术后并发症的风险一般较低。我们得出结论,注射 80mg/kg STZ 可诱导具有中度损伤的糖尿病。低剂量 STZ 联合部分胰切除术是诱导恒河猴发生糖尿病的一种更安全、更可重复的方法。